Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells.
Palchetti S, Pozzi D, Marchini C, Amici A, Andreani C, Bartolacci C, Digiacomo L, Gambini V, Cardarelli F, Di Rienzo C, Peruzzi G, Amenitsch H, Palermo R, Screpanti I, Caracciolo G. Palchetti S, et al. Among authors: gambini v. Nanomedicine. 2017 Feb;13(2):681-691. doi: 10.1016/j.nano.2016.08.019. Epub 2016 Aug 23. Nanomedicine. 2017. PMID: 27565691
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells.
Montani M, Pazmay GVB, Hysi A, Lupidi G, Pettinari R, Gambini V, Tilio M, Marchetti F, Pettinari C, Ferraro S, Iezzi M, Marchini C, Amici A. Montani M, et al. Among authors: gambini v. Pharmacol Res. 2016 May;107:282-290. doi: 10.1016/j.phrs.2016.03.032. Epub 2016 Mar 30. Pharmacol Res. 2016. PMID: 27038531
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
Tilio M, Gambini V, Wang J, Garulli C, Kalogris C, Andreani C, Bartolacci C, Elexpuru Zabaleta M, Pietrella L, Hysi A, Iezzi M, Belletti B, Orlando F, Provinciali M, Galeazzi R, Marchini C, Amici A. Tilio M, et al. Among authors: gambini v. Cancer Lett. 2016 Oct 10;381(1):76-84. doi: 10.1016/j.canlet.2016.07.028. Epub 2016 Jul 27. Cancer Lett. 2016. PMID: 27475932
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer.
Bartolacci C, Andreani C, Curcio C, Occhipinti S, Massaccesi L, Giovarelli M, Galeazzi R, Iezzi M, Tilio M, Gambini V, Wang J, Marchini C, Amici A. Bartolacci C, et al. Among authors: gambini v. Cancer Immunol Res. 2018 Dec;6(12):1486-1498. doi: 10.1158/2326-6066.CIR-18-0179. Epub 2018 Oct 16. Cancer Immunol Res. 2018. PMID: 30327365